Finance

Lists
Why is 300966 up 3.47%?
Dive Deeper
300966:SHE
Hubei Goto Biopharm Group Co Ltd
CN¥23.85
+3.47%
(+0.80) 1D
Oct 16, 12:06:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300966...
Open
CN¥23.53
High
CN¥23.93
Low
CN¥22.95
Mkt. cap
2.84B
Avg. vol.
2.15M
Volume
946.70K
Dividend
0.19%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
52-wk high
CN¥32.58
52-wk low
CN¥18.44
EPS
-CN¥0.84
Shares outstanding
115.28M
No. of employees
893
Open
CN¥23.53
High
CN¥23.93
Low
CN¥22.95
Mkt. cap
2.84B
Avg. vol.
2.15M
Volume
946.70K
Dividend
0.19%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
52-wk high
CN¥32.58
52-wk low
CN¥18.44
EPS
-CN¥0.84
Shares outstanding
115.28M
No. of employees
893
News stories
From web sources and news partners
About Hubei Goto Biopharm Group Co Ltd
CEO-
Employees893
FoundedMay 15, 2006
Headquarters-
SectorBiotechnology
Websitegotopharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
152.67M
151.11M
161.94M
184.34M
Cost of goods sold
131.32M
162.57M
124.94M
167.80M
Cost of revenue
131.32M
162.57M
124.94M
167.80M
Research and development expenses
15.43M
18.49M
12.31M
17.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.81M
17.63M
11.98M
18.53M
Operating expense
33.24M
32.24M
22.81M
36.19M
Total operating expenses
164.56M
194.81M
147.76M
203.99M
Operating income
-11.89M
-43.70M
14.18M
-19.66M
Other non operating income
-1.80M
1.53M
-1.30M
1.07M
EBT including unusual items
-30.50M
-51.56M
-1.28M
-36.93M
EBT excluding unusual items
-23.92M
-57.37M
128.89K
-34.23M
Income tax expense
-7.72M
-7.26M
-2.40M
2.55M
Effective tax rate
25.33%
14.08%
187.86%
-6.90%
Other operating expenses
-3.09M
-3.56M
-3.13M
-1.70M
Net income
-21.28M
-40.92M
3.20M
-36.04M
Net profit margin
-13.94%
-27.08%
1.98%
-19.55%
Earnings per share
-
-
-
-
Interest and investment income
370.64K
24.69K
67.99K
58.16K
Interest expense
-10.68M
-13.61M
-12.82M
-13.13M
Net interest expenses
-10.30M
-13.58M
-12.75M
-13.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.14M
-14.86M
43.02M
15.25M
Gain or loss from assets sale
-1.57M
1.44M
-
131.26K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps